Novel applications of an adaptive optics visual simulator in the clinical setting

Ronald R. Krueger, Alexandra Abdala, Karolinne Rocha, Nicolas Chateau, Laurent Vabre

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Purpose: To evaluate the clinical benefit of using an adaptive optics visual simulator (AOVS) and its impact in different clinical settings. Methods: An adaptive optics visual simulator performed the experimental procedure and was used to optically introduce aberrations in 9 normal eyes for visual acuity (VA) change, and in 10 cyclopleged eyes for enhancing depth of focus (DoF). AOVS was also used to correct 20 highly aberrated eyes. Results: The correction/induction of high order aberrations (HOA) alters the best-corrected visual acuity (BCVA) by a mean of ∼1 to 1.5 lines compared to the best spectacle correction. The depth of focus (DoF) was most enhanced (∼2.0 D) with the introduction of negative and positive spherical aberration of 0.6 μm magnitude. The correction of HOAs in highly aberrated eyes improved BCVA by a mean of ∼1.5 to 2 lines in two groups of pathological eyes. Conclusions: Aberrations have differing effects according to their clinical use. The AOVS defines the clinical response of HOAs on VA, visual perceptions and DoF.

Original languageEnglish (US)
Title of host publicationOphthalmic Technologies XX
DOIs
StatePublished - Dec 1 2010
EventOphthalmic Technologies XX - San Francisco, CA, United States
Duration: Jan 23 2010Jan 25 2010

Publication series

NameProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume7550
ISSN (Print)1605-7422

Conference

ConferenceOphthalmic Technologies XX
CountryUnited States
CitySan Francisco, CA
Period1/23/101/25/10

Fingerprint

Adaptive optics
visual acuity
Aberrations
adaptive optics
simulators
Simulators
Visual Acuity
aberration
Visual Perception
visual perception
induction
4-hexyloxyaniline

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Atomic and Molecular Physics, and Optics
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Krueger, R. R., Abdala, A., Rocha, K., Chateau, N., & Vabre, L. (2010). Novel applications of an adaptive optics visual simulator in the clinical setting. In Ophthalmic Technologies XX [755013] (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 7550). https://doi.org/10.1117/12.843094

Novel applications of an adaptive optics visual simulator in the clinical setting. / Krueger, Ronald R.; Abdala, Alexandra; Rocha, Karolinne; Chateau, Nicolas; Vabre, Laurent.

Ophthalmic Technologies XX. 2010. 755013 (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 7550).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Krueger, RR, Abdala, A, Rocha, K, Chateau, N & Vabre, L 2010, Novel applications of an adaptive optics visual simulator in the clinical setting. in Ophthalmic Technologies XX., 755013, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 7550, Ophthalmic Technologies XX, San Francisco, CA, United States, 1/23/10. https://doi.org/10.1117/12.843094
Krueger RR, Abdala A, Rocha K, Chateau N, Vabre L. Novel applications of an adaptive optics visual simulator in the clinical setting. In Ophthalmic Technologies XX. 2010. 755013. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE). https://doi.org/10.1117/12.843094
Krueger, Ronald R. ; Abdala, Alexandra ; Rocha, Karolinne ; Chateau, Nicolas ; Vabre, Laurent. / Novel applications of an adaptive optics visual simulator in the clinical setting. Ophthalmic Technologies XX. 2010. (Progress in Biomedical Optics and Imaging - Proceedings of SPIE).
@inproceedings{1384eef828214d3e9afbc30c9a981f06,
title = "Novel applications of an adaptive optics visual simulator in the clinical setting",
abstract = "Purpose: To evaluate the clinical benefit of using an adaptive optics visual simulator (AOVS) and its impact in different clinical settings. Methods: An adaptive optics visual simulator performed the experimental procedure and was used to optically introduce aberrations in 9 normal eyes for visual acuity (VA) change, and in 10 cyclopleged eyes for enhancing depth of focus (DoF). AOVS was also used to correct 20 highly aberrated eyes. Results: The correction/induction of high order aberrations (HOA) alters the best-corrected visual acuity (BCVA) by a mean of ∼1 to 1.5 lines compared to the best spectacle correction. The depth of focus (DoF) was most enhanced (∼2.0 D) with the introduction of negative and positive spherical aberration of 0.6 μm magnitude. The correction of HOAs in highly aberrated eyes improved BCVA by a mean of ∼1.5 to 2 lines in two groups of pathological eyes. Conclusions: Aberrations have differing effects according to their clinical use. The AOVS defines the clinical response of HOAs on VA, visual perceptions and DoF.",
author = "Krueger, {Ronald R.} and Alexandra Abdala and Karolinne Rocha and Nicolas Chateau and Laurent Vabre",
year = "2010",
month = "12",
day = "1",
doi = "10.1117/12.843094",
language = "English (US)",
isbn = "9780819479464",
series = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",
booktitle = "Ophthalmic Technologies XX",

}

TY - GEN

T1 - Novel applications of an adaptive optics visual simulator in the clinical setting

AU - Krueger, Ronald R.

AU - Abdala, Alexandra

AU - Rocha, Karolinne

AU - Chateau, Nicolas

AU - Vabre, Laurent

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Purpose: To evaluate the clinical benefit of using an adaptive optics visual simulator (AOVS) and its impact in different clinical settings. Methods: An adaptive optics visual simulator performed the experimental procedure and was used to optically introduce aberrations in 9 normal eyes for visual acuity (VA) change, and in 10 cyclopleged eyes for enhancing depth of focus (DoF). AOVS was also used to correct 20 highly aberrated eyes. Results: The correction/induction of high order aberrations (HOA) alters the best-corrected visual acuity (BCVA) by a mean of ∼1 to 1.5 lines compared to the best spectacle correction. The depth of focus (DoF) was most enhanced (∼2.0 D) with the introduction of negative and positive spherical aberration of 0.6 μm magnitude. The correction of HOAs in highly aberrated eyes improved BCVA by a mean of ∼1.5 to 2 lines in two groups of pathological eyes. Conclusions: Aberrations have differing effects according to their clinical use. The AOVS defines the clinical response of HOAs on VA, visual perceptions and DoF.

AB - Purpose: To evaluate the clinical benefit of using an adaptive optics visual simulator (AOVS) and its impact in different clinical settings. Methods: An adaptive optics visual simulator performed the experimental procedure and was used to optically introduce aberrations in 9 normal eyes for visual acuity (VA) change, and in 10 cyclopleged eyes for enhancing depth of focus (DoF). AOVS was also used to correct 20 highly aberrated eyes. Results: The correction/induction of high order aberrations (HOA) alters the best-corrected visual acuity (BCVA) by a mean of ∼1 to 1.5 lines compared to the best spectacle correction. The depth of focus (DoF) was most enhanced (∼2.0 D) with the introduction of negative and positive spherical aberration of 0.6 μm magnitude. The correction of HOAs in highly aberrated eyes improved BCVA by a mean of ∼1.5 to 2 lines in two groups of pathological eyes. Conclusions: Aberrations have differing effects according to their clinical use. The AOVS defines the clinical response of HOAs on VA, visual perceptions and DoF.

UR - http://www.scopus.com/inward/record.url?scp=79953049267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953049267&partnerID=8YFLogxK

U2 - 10.1117/12.843094

DO - 10.1117/12.843094

M3 - Conference contribution

AN - SCOPUS:79953049267

SN - 9780819479464

T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

BT - Ophthalmic Technologies XX

ER -